Isoproterenol
It is used as a bronchodilator and to treat bradycardia and heart block.
Isoproterenol stimulates both beta-1 and beta-2 adrenergic receptors, leading to increased heart rate, myocardial contractility, and vasodilation.
It is also employed in research settings to induce cardiac hypertrophy and other cardiovascular effects in animal models.
Optimizing isoproterenol research can be challenging, but PubCompare.ai's AI-driven comparison and validation platform can help researchers locate the best protocols and products from literature, preprints, and patents, enhancing reproducibility and reliability.
Experince the power of data-driven decision making for your isoproterenol studies.
Most cited protocols related to «Isoproterenol»
Cardiac differentiation was induced from monolayer cultures on Matrigel in a serum-free medium (BSA, polyvinyl alcohol, essential lipids [BPEL]) as described in the
The composition of the defined cardiomyocyte medium used in the MYBPC3 shRNA experiment can be found in the
Most recents protocols related to «Isoproterenol»
Example 1
This example demonstrates that the binding interaction of βarr with the β2-adrenergic receptor (β2AR).
The binding of βarr to GPCRs is mainly initiated through an interaction with the phosphorylated receptor C terminus, and conformational changes induced in βarr by this interaction promote coupling to the receptor TM core, as shown in
To verify that this apparent lack of interaction with βarr is not simply due to poor complex stability, two assays capable of detecting complex formation in situ were performed. First, competition radioligand binding was used to measure the allosteric effects of transducers on ligand binding to the receptor. As described by the ternary complex model, first for G proteins and later for βarrs, ligand-induced changes in receptor conformation enhance the binding and affinity of transducers, which reciprocally increase ligand affinity by stabilizing an active receptor state (De Lean A, et al. (1980) J Biol Chem 255(15):7108-7117., Gurevich V V, et al. (1997) J Biol Chem 272(46):28849-28852). When wild-type (WT) β2AR was reconstituted in high-density lipoprotein (HDL) particles to mimic a cellular membrane environment (Denisov I G & Sligar S G (2016) Nat Struct Mol Biol 23(6):481-486), G protein enhanced the affinity of the full agonist isoproterenol for non-phosphorylated HDL-β2AR by nearly 1000-fold, as expected, but βarr1 had no effect even at micromolar concentrations, as shown in
Second, to directly monitor β2AR conformational changes associated with activation, the C265 at the cytoplasmic end of TM6 was labeled with monobromobimane, an environmentally sensitive fluorophore. Receptor activation leads to an outward movement of TM6 that places the bimane label in a more solvent-exposed position, causing a decrease in fluorescence and a shift in λmax (Yao X J, et al. (2009) Proc Natl Acad Sci USA 106(23):9501-9506). Indeed, isoproterenol reduced β2AR-bimane fluorescence compared to control (DMSO), and addition of Gs but not βarr1 further attenuated fluorescence, as shown in
The results of this example demonstrate that non-phosphorylated β2AR fails to form a productive interaction with βarr.
All animal work has been approved by the BRFAA ethics committee and the Attica Veterinary Department (Animal Licence; 60876/23-1-20). All animals used were 2–3 months of age upon the time of ischemia/reperfusion (I/R) or isoproterenol administration experiments following relevant inclusion/exclusion guideline criteria73 (link).
Top products related to «Isoproterenol»
More about "Isoproterenol"
It acts as a non-selective agonist, stimulating both beta-1 and beta-2 adrenergic receptors.
This leads to increased heart rate, myocardial contractility, and vasodilation, making it a valuable tool in the treatment of bradycardia, heart block, and as a bronchodilator for respiratory conditions like asthma.
Researchers commonly use isoproterenol in animal models to induce cardiac hypertrophy and study other cardiovascular effects.
However, optimizing isoproterenol research can be challenging.
Factors like dosage, administration route, and timing can significantly impact the results.
Fortunately, AI-driven platforms like PubCompare.ai can help researchers identify the best protocols and products from literature, preprints, and patents, enhancing the reproducibility and reliability of their isoproterenol studies.
In addition to isoproterenol, related compounds like isoprenaline, free glycerol reagent, insulin, propranolol (a beta-blocker), and dexamethasone (a corticosteroid) may also be relevant in cardiovascular and metabolic research.
By leveraging the power of data-driven decision making, researchers can optimize their use of these compounds and gain deeper insights into the underlying mechanisms and therapeutic potential.
Experience the benefits of AI-powered research optimization for your isoproterenol and related studies.